KR19990087084A - 이부프로펜 투여형 - Google Patents

이부프로펜 투여형 Download PDF

Info

Publication number
KR19990087084A
KR19990087084A KR1019980706472A KR19980706472A KR19990087084A KR 19990087084 A KR19990087084 A KR 19990087084A KR 1019980706472 A KR1019980706472 A KR 1019980706472A KR 19980706472 A KR19980706472 A KR 19980706472A KR 19990087084 A KR19990087084 A KR 19990087084A
Authority
KR
South Korea
Prior art keywords
ibuprofen
dosage form
sodium
carrier material
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019980706472A
Other languages
English (en)
Korean (ko)
Inventor
이안 애슐리 프라이스
Original Assignee
하우틴 아이 에이
더 부츠 캄파니 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하우틴 아이 에이, 더 부츠 캄파니 피엘씨 filed Critical 하우틴 아이 에이
Publication of KR19990087084A publication Critical patent/KR19990087084A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019980706472A 1996-02-21 1997-02-19 이부프로펜 투여형 Ceased KR19990087084A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9603699.1 1996-02-21
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition

Publications (1)

Publication Number Publication Date
KR19990087084A true KR19990087084A (ko) 1999-12-15

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980706472A Ceased KR19990087084A (ko) 1996-02-21 1997-02-19 이부프로펜 투여형

Country Status (25)

Country Link
US (1) US20020034540A1 (https=)
EP (1) EP0881899B1 (https=)
JP (2) JP2000507922A (https=)
KR (1) KR19990087084A (https=)
CN (1) CN1215989A (https=)
AT (1) ATE273696T1 (https=)
AU (1) AU722991B2 (https=)
BG (1) BG64165B1 (https=)
CA (1) CA2246344C (https=)
CZ (1) CZ298371B6 (https=)
DE (1) DE69730314T2 (https=)
DK (1) DK0881899T3 (https=)
ES (1) ES2227670T3 (https=)
GB (1) GB9603699D0 (https=)
HU (1) HUP9901454A3 (https=)
IL (1) IL125803A0 (https=)
NO (1) NO983825L (https=)
NZ (1) NZ331416A (https=)
PL (1) PL187383B1 (https=)
PT (1) PT881899E (https=)
RU (1) RU2182000C2 (https=)
SK (1) SK285032B6 (https=)
UA (1) UA55407C2 (https=)
WO (1) WO1997030699A2 (https=)
ZA (1) ZA971446B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
US20020192161A1 (en) * 2001-04-10 2002-12-19 Fahkreddin Jamali Animal model for evaluating analgesics
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CA2510319A1 (en) * 2002-12-20 2004-07-15 Thomas J. Smith High pressure compaction for pharmaceutical formulations
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
GEP20094671B (en) * 2004-06-29 2009-04-27 Nycomed Danmark Aps Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
WO2006016126A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a nsaid and a sugar alcohol made by melt extrusion
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
WO2006056042A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
WO2006084793A2 (de) * 2005-02-09 2006-08-17 Boehringer Ingelheim International Gmbh Filmtabletten enthaltend ibuprofen-lysinat
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
EP2559430B1 (en) 2005-03-22 2015-06-24 Losan Pharma GmbH Solubilized Ibuprofen
JP2009508951A (ja) * 2005-09-19 2009-03-05 アルベマール・コーポレーシヨン カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US9757455B2 (en) 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
AU2007338843B2 (en) * 2006-12-20 2013-05-09 Teva Women's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EP2291233B1 (en) * 2008-05-09 2019-09-04 Atacama Labs Oy Method for dry granulation
EP2309988B1 (en) 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
ES2654331T3 (es) * 2009-06-22 2018-02-13 Wyeth Llc Comprimidos de ibuprofeno de sodio y procedimientos de fabricación de composiciones farmacéuticas que incluyen ibuprofeno de sodio
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
AU2015283133B2 (en) 2014-07-02 2019-05-16 ObsEva SA Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime useful in methods of treating conditions related to the OT-R activity
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
WO1988003021A2 (en) * 1986-10-22 1988-05-05 The Upjohn Company Treatment of gingivitis with ibuprofen or flurbiprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
KR100198044B1 (ko) * 1991-05-13 1999-06-15 아이 에이 호틴 이부프로펜 염을 포함하는 약제학적 조성물
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제

Also Published As

Publication number Publication date
DK0881899T3 (da) 2004-12-20
WO1997030699A3 (en) 1997-10-09
EP0881899B1 (en) 2004-08-18
CA2246344C (en) 2009-01-20
US20020034540A1 (en) 2002-03-21
CN1215989A (zh) 1999-05-05
NO983825D0 (no) 1998-08-20
ES2227670T3 (es) 2005-04-01
JP2009073847A (ja) 2009-04-09
UA55407C2 (uk) 2003-04-15
BG64165B1 (bg) 2004-03-31
CZ298371B6 (cs) 2007-09-12
HUP9901454A2 (hu) 1999-08-30
RU2182000C2 (ru) 2002-05-10
AU1793797A (en) 1997-09-10
PL187383B1 (pl) 2004-06-30
DE69730314T2 (de) 2005-08-18
CZ261798A3 (cs) 1998-11-11
IL125803A0 (en) 1999-04-11
DE69730314D1 (de) 2004-09-23
ATE273696T1 (de) 2004-09-15
CA2246344A1 (en) 1997-08-28
NO983825L (no) 1998-10-20
SK285032B6 (sk) 2006-05-04
JP2000507922A (ja) 2000-06-27
GB9603699D0 (en) 1996-04-17
PL328465A1 (en) 1999-02-01
EP0881899A2 (en) 1998-12-09
ZA971446B (en) 1997-11-25
WO1997030699A2 (en) 1997-08-28
NZ331416A (en) 2000-02-28
PT881899E (pt) 2004-12-31
BG102744A (bg) 1999-05-31
SK114298A3 (en) 1999-01-11
AU722991B2 (en) 2000-08-17
HUP9901454A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
KR19990087084A (ko) 이부프로펜 투여형
JP2009073847A6 (ja) イブプロフェンの剤型
BG65007B1 (bg) Мигновено топяща се орална дозирана форма
US4711777A (en) Pharmaceutical tablets
JP2004315483A (ja) 口腔内崩壊錠剤
JP4438121B2 (ja) 口腔内速崩錠及びその製造方法
EP0200252B1 (en) Tablets comprising trimethoprim and a sulfonamide
EP0975337B1 (en) Fast release compressed tablet of flurbiprofen
WO2006056042A1 (en) Nsaid compositions exhibiting clinical superiority
EP1518551B1 (en) Solid dosage form comprising caffeine
JP2012046454A (ja) 内服用錠剤およびその製造方法
KR20150096787A (ko) Ｎ-[5-[2-(3,5-디메톡시페닐)에틸]-2ｈ-피라졸-3-일]-4-[(3ｒ,5ｓ)-3,5-디메틸피페라진-1-일]벤즈아미드의 약학 제제
JP2022540170A (ja) 医薬調製物
EP2848260B1 (en) Novel formulations of thiocolchicoside
MXPA98006688A (en) Dosage form of ibuprophene
RU2353352C1 (ru) Твердая лекарственная форма, обладающая противовоспалительной, анальгезирующей, жаропонижающей активностью, и способ ее получения
Karemore et al. FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF AN ANTIDIABETIC DRUG
JP2002128670A (ja) 錠剤用医薬組成物
MXPA00006125A (en) Flash-melt oral dosage formulation

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19980820

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20020219

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20031226

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20040322

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20031226

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I